South Africa Cervical Cancer Screening, Diagnostics, And Pre-cancerous Dysplasia Lesion Treatment Market Size & Outlook
Related Markets
South Africa cervical cancer screening, diagnostics, and pre-cancerous dysplasia lesion treatment market highlights
- The South Africa cervical cancer screening, diagnostics, and pre-cancerous dysplasia lesion treatment market generated a revenue of USD 49.9 million in 2024 and is expected to reach USD 81.1 million by 2035.
- The South Africa market is expected to grow at a CAGR of 4.6% from 2025 to 2035.
- In terms of segment, cervical cancer screening was the largest revenue generating type in 2024.
- Cervical Cancer Screening is the most lucrative type segment registering the fastest growth during the forecast period.
Cervical cancer screening, diagnostics, and pre-cancerous dysplasia lesion treatment market data book summary
| Market revenue in 2024 | USD 49.9 million |
| Market revenue in 2035 | USD 81.1 million |
| Growth rate | 4.6% (CAGR from 2025 to 2035) |
| Largest segment | Cervical cancer screening |
| Fastest growing segment | Cervical Cancer Screening |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2035 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Cervical Cancer Screening, Cervical Cancer Diagnostics, Pre-cancerous Lesion Treatment |
Other key industry trends
- In terms of revenue, South Africa accounted for 0.6% of the global cervical cancer screening, diagnostics, and pre-cancerous dysplasia lesion treatment market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2035.
- In Middle East & Africa, Saudi Arabia cervical cancer screening, diagnostics, and pre-cancerous dysplasia lesion treatment market is projected to lead the regional market in terms of revenue in 2035.
- UAE is the fastest growing regional market in Middle East & Africa and is projected to reach USD 46.8 million by 2035.
Cervical cancer screening was the largest segment with a revenue share of 50.7% in 2024. Horizon Databook has segmented the South Africa cervical cancer screening, diagnostics, and pre-cancerous dysplasia lesion treatment market based on cervical cancer screening, cervical cancer diagnostics, pre-cancerous lesion treatment covering the revenue growth of each sub-segment from 2018 to 2035.
The South African market for cervical cancer screening, diagnostics, and treatment of pre-cancerous dysplasia lesions is growing due to the high prevalence of the disease. Among the 22.2 million women at risk, an estimated 10,702 new cases and 5,870 deaths occur annually.
Cervical cancer is the second most common cancer among women and the leading cause of cancer-related deaths in those aged 15–44. HPV-16 and HPV-18 are responsible for 64.2% of cases. South Africa introduced HPV vaccination in 2014, achieving a 34% coverage rate for the final dose by 2021.
Screening for cervical cancer is recommended for women aged 25–55, with cytology performed every five years or HPV testing every ten years. Current screening coverage stands at 44% for women aged 25–65 and 52% for those aged 30–49.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Cervical Cancer Screening, Diagnostics, and Pre-cancerous Dysplasia Lesion Treatment Market Scope
Cervical Cancer Screening, Diagnostics, and Pre-cancerous Dysplasia Lesion Treatment Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| MedGyn Products | View profile | 51-100 | Addison, Illinois, United States, North America | https://www.medgyn.com |
| Utah Medical Products Inc | View profile | 190 | 7043 South 300 West, Midvale, UT, United States, 84047 | http://www.utahmed.com |
| CooperSurgical | View profile | 501-1000 | Trumbull, Connecticut, United States, North America | http://www.coopersurgical.com |
| Hologic Inc | View profile | 6990 | 250 Campus Drive, Marlborough, MA, United States, 01752 | http://www.hologic.com |
| Qiagen NV | View profile | 5900 | Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL | https://www.qiagen.com |
| Becton Dickinson & Co | View profile | 73000 | 1 Becton Drive, Franklin Lakes, NJ, United States, 07417-1880 | https://www.bd.com |
| Abbott Laboratories | View profile | 114000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | https://www.abbottinvestor.com |
| Roche Holding AG ADR | View profile | 103605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | https://www.roche.com |
South Africa Type - Cervical Cancer Screening, Diagnostics, And Pre-cancerous Dysplasia Lesion Treatment Market size, 2024 - 2035 (US$M)
South Africa Cervical Cancer Screening, Diagnostics, and Pre-cancerous Dysplasia Lesion Treatment Market Outlook Share, 2024 & 2035 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
